GSK plc
GSK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 1,048 institutions reported holding it in 13F filings for Q2 2026, worth $18.2B in total; no superinvestor holds it.
Other share classesGLAXF
Q2 2023 vs. Q1 2023
How the institutions holding GSK plc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 811 | 5 | 829 | +23 |
| Shares | 272.7M | 86.5K | 278.0M | +5.44M (+2.0%) |
| Value | $9.68B | $3.19M | $9.91B | +$231.3M (+2.4%) |
5 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (81)
Institutions that held GSK plc at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (58)
Institutions that held GSK plc at the end of Q1 2023 and filed for Q2 2023 without it.
Not filed for Q2 2023 yet (5)
Institutions that held GSK plc at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Old Port Advisors | 64,134 | $2.40M |
| Cerro Pacific Wealth Advisors LLC | 14,127 | $502.6K |
| ETF Managers Group, LLC | 3,992 | $142.0K |
| Ahrens Investment Partners LLC | 2,687 | $95.6K |
| Householder Group Estate & Retirement Specialist, LLC | 1,576 | $56.0K |